Clinical Trial Update: A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

Genfit's Phase 2 trial of the investigational medicine VS-01 for hepatic encephalopathy in patients with acute-on-chronic liver failure and decompensated cirrho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis
• Hepatic Encephalopathy
• On Chronic Liver Failure

Drugs mentioned

• VS-01

Snippet

Sponsor: Genfit | Conditions: Hepatic Encephalopathy, Acute on Chronic Liver Failure (ACLF) | Phase 2 | Status: TERMINATED